Data Under Review
Some valuation figures for this stock are being recalibrated. Hidden fields will return after data review.
Reported as ticker: ASHIMASYN· We're continuously improving data quality. Contact support if this persists.
ASHIMA LTD
ASHIMASYN · General/Diversified · NSE
₹16
Current Market Price
Fair Value (DCF)
₹0
Margin of Safety
-100.0%
Updated just now
YieldIQ Score
15/100
Piotroski F-Score
4/9
Economic Moat
None
Confidence
11%
ROE
—
Debt/Equity
0.58
WACC
11.1%
Market Cap
₹312 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
160.0%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
—
Leverage vs earnings
Interest Coverage
1.0×
EBIT covers interest
Current Ratio
4.48×
Short-term liquidity
Asset Turnover
0.02×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹16.29
Bear case
₹0
MoS -Infinity%
Base case
₹0
MoS -Infinity%
Bull case
₹0
MoS -Infinity%
Ratio Trends
ASHIMASYN · last 9 annual periods
ROE
-6.4%
ROCE
1.7%
Operating Margin
—
Debt / Equity
0.38×
PE
9.2×
EV / EBITDA
—
Historical Financials
ASHIMASYN · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹141 Cr | ₹207 Cr | ₹207 Cr | ₹329 Cr | ₹10.5 Cr | -47.8% |
| EBITDA | — | ₹32.5 Cr | ₹-1.6 Cr | ₹73.5 Cr | ₹7.2 Cr | -31.4% |
| EBIT | ₹-8.4 Cr | ₹28.2 Cr | ₹-5.4 Cr | ₹66.5 Cr | — | — |
| PAT | ₹-11.5 Cr | ₹17.9 Cr | ₹-6.6 Cr | ₹96.4 Cr | ₹-19.0 Cr | — |
| EPS (diluted) | ₹-0.60 | ₹-0.52 | ₹-0.40 | ₹5.03 | — | — |
| CFO | ₹-8.1 Cr | ₹-26.4 Cr | ₹-23.9 Cr | ₹-38.4 Cr | ₹-19.9 Cr | — |
| CapEx | — | — | — | — | ₹-0.3 Cr | — |
| FCF | — | — | — | — | ₹-20.2 Cr | — |
| Total Assets | — | ₹318 Cr | ₹320 Cr | ₹544 Cr | ₹502 Cr | +12.1% |
| Total Debt | — | — | ₹0.1 Cr | ₹13.2 Cr | ₹113 Cr | +585.4% |
| Shareholders' Equity | — | — | ₹220 Cr | ₹317 Cr | ₹299 Cr | +7.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ASHIMASYN vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| SUMIT SUMIT | — | — | Pending | 6.1% | — |
| RVHL RVHL | — | — | Pending | -1.1% | — |
| SHRADHA SHRADHA | — | — | Pending | 9.7% | — |
| NILAINFRA NILAINFRA | — | — | Pending | 12.5% | — |
| EMAMIREAL EMAMIREAL | — | — | Pending | 78.1% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ASHIMASYN in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ASHIMASYN →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ASHIMASYN →
Compare
Head-to-head with peers
Compare ASHIMASYN side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ASHIMASYNNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.